Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Annals of Oncology

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/annonc/mdr300PMID 21693769
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical relevance of contrast-enhanced ultrasound in monitoring anti-angiogenic therapy of cancer: current status and perspectives.

  2010cited by this paper
• Fighting cancer: from the bench to bedside using second generation cationic liposomal therapeutics.

  2009cited by this paper
• DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study

  2009cited by this paper
• Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.

  2009cited by this paper
• Phase I Study of the Angiogenesis Inhibitor BIBF 1120 in Patients with Advanced Solid Tumors

  2009cited by this paper
• Tumor‐selective vessel occlusions by platelets after vascular targeting chemotherapy using paclitaxel encapsulated in cationic liposomes

  2008cited by this paper
• First-line treatment of inoperable pancreatic adenocarcinoma with lipid complexed paclitaxel nanoparticles plus gemcitabine compared with gemcitabine monotherapy. A prospective RCT - phase II study

  2008cited by this paper
• Paclitaxel Encapsulated in Cationic Liposomes Increases Tumor Microvessel Leakiness and Improves Therapeutic Efficacy in Combination with Cisplatin

  2008cited by this paper
• Dual targeting of vascular endothelial growth factor (VEGF) with sorafenib and bevacizumab: Clinical and translational results

  2007cited by this paper
• Functional imaging of colorectal cancer angiogenesis.

  2007cited by this paper
• DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents

  2007cited by this paper
• Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors.

  2007cited by this paper
• Paclitaxel encapsulated in cationic lipid complexes (MBT-0206) impairs functional tumor vascular properties as detected by dynamic contrast enhanced magnetic resonance imaging

  2006cited by this paper
• Correlation Between Estimates of Tumor Perfusion From Microbubble Contrast‐Enhanced Sonography and Dynamic Contrast‐Enhanced Magnetic Resonance Imaging

  2006cited by this paper
• Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer.

  2006cited by this paper
• Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.

  2006cited by this paper
• Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths

  2005cited by this paper
• Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours.

  2005cited by this paper
• Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials.

  2005cited by this paper
• Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study.

  2005cited by this paper
• Phase II Study of the Flk-1 Tyrosine Kinase Inhibitor SU5416 in Advanced Melanoma

  2004cited by this paper
• Neovascular targeting chemotherapy: Encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature

  2004cited by this paper
• Magnetic Resonance Imaging Measurements of the Response of Murine and Human Tumors to the Vascular-Targeting Agent ZD6126

  2004cited by this paper
• Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy.

  2003cited by this paper
• On the transient phase of balanced SSFP sequences

  2003cited by this paper
• Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model.

  2003cited by this paper
• Continuous low-dose anti-angiogenic/ metronomic chemotherapy: from the research laboratory into the oncology clinic.

  2002cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors

  2000cited by this paper
• Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols

  1999cited by this paper
• Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion.

  1998cited by this paper
• Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging

  1997cited by this paper

• Charge Effects: Influence of Surface Charge on Protein Corona Adsorption Behavior on Liposomal Formulations

  2026cites this paper
• Fibroblast Activation Protein-Targeted CAR-T Cells Induce Apoptosis in Murine Cardiac Myofibroblasts

  2025cites this paper
• Mechanobiologically Engineered Mimicry of Extracellular Vesicles for Improved Systemic Biodistribution and Anti‐Inflammatory Treatment Efficacy in Rheumatoid Arthritis

  2025cites this paper
• Nanomaterials in Drug Delivery: Strengths and Opportunities in Medicine

  2024cites this paper
• A Library of Custom PEG-Lipids reveals a Double-PEG-Lipid with Drastically Enhanced Paclitaxel Solubility and Human Cancer Cell Cytotoxicity when used in Fluid Micellar Nanoparticles

  2024cites this paper
• Sialic Acid Conjugate-Modified Cationic Liposomal Paclitaxel for Targeted Therapy of Lung Metastasis in Breast Cancer: What a Difference the Cation Content Makes.

  2024cites this paper
• Liposomal Nanoformulation-encapsulated Paclitaxel for Reducing Chemotherapy Side Effects in Lung Cancer Treatments: Recent Advances and Future Outlooks.

  2024cites this paper
• Nanoparticle-based materials in anticancer drug delivery: Current and future prospects

  2023cites this paper
• A Critical Appraisal of Lipid Nanoparticles Deployed in Cancer Pharmacotherapy.

  2023cites this paper
• Exploration of mRNA nanoparticles based on DOTAP through optimization of the helper lipids

  2023cites this paper
• Nanomedicines: Impactful Approaches for Targeting Pulmonary Diseases.

  2023cites this paper
• Nanomedicines: intervention in inflammatory pathways of cancer

  2023cites this paper
• Liposomes in Cancer Therapy: How Did We Start and Where Are We Now

  2023cites this paper
• Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives.

  2023cites this paper
• Lipids with negative spontaneous curvature decrease the solubility of the cancer drug paclitaxel in liposomes

  2023cites this paper
• Lipids with negative spontaneous curvature decrease the solubility of the cancer drug paclitaxel in liposomes

  2023cites this paper
• Novel taxanes in development: hopes or hypes?

  2022cites this paper
• Paclitaxel-loaded PEGylated Cationic Lipid Nanodiscs and Small Liposomes with Protruding Brush Conformation PEG-chains Show Tumor Penetration and Proapoptotic Caspase-3 Activation

  2022cites this paper
• Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs.

  2022cites this paper
• Clinical application of nano-targeting for enhancing chemotherapeutic efficacy and safety in cancer management.

  2022cites this paper
• Application of nanocarriers for paclitaxel delivery and chemotherapy of cancer

  2022cites this paper
• Paclitaxel-Loaded Cationic Fluid Lipid Nanodiscs and Liposomes with Brush-Conformation PEG Chains Penetrate Breast Tumors and Trigger Caspase-3 Activation.

  2022cites this paper
• Nanodevices for Deep Cartilage Penetration.

  2022cites this paper
• Strategies for the drug discovery and development of taxane anticancer therapeutics

  2022cites this paper
• Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivo.

  2022cites this paper
• Nano-Chemotherapy synergize with immune checkpoint inhibitor- A better option?

  2022cites this paper
• Nanomedicine Tactics in Cancer Treatment: Challenge and Hope.

  2022cites this paper
• Paclitaxel loading in cationic liposome vectors is enhanced by replacement of oleoyl with linoleoyl tails with distinct lipid shapes

  2021cites this paper
• Investigating the Application of Liposomes as Drug Delivery Systems for the Diagnosis and Treatment of Cancer

  2021cites this paper
• Experimental study on preparation and anti-tumor efficiency of nanoparticles targeting M2 macrophages

  2021cites this paper
• Emerging advances in cationic liposomal cancer nanovaccines: opportunities and challenges.

  2021cites this paper
• Current Perspectives on Taxanes: Focus on Their Bioactivity, Delivery and Combination Therapy

  2021cites this paper
• Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics

  2021cites this paper
• Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer

  2020cites this paper
• Axial Pharmaceutical Properties of Liposome in Cancer Therapy: Recent Advances and Perspectives.

  2020cites this paper
• 3D approaches to model the tumor microenvironment of pancreatic cancer

  2020cites this paper
• Advances of the Application of Liposomal Nanosystems in Anticancer Therapy.

  2020cites this paper
• Enhanced Loading of Paclitaxel in Cationic Liposomes by Replacement of Oleoyl with Linoleoyl Lipid Tails with Benefits in Cancer Therapeutics from In Vitro Studies

  2020cites this paper
• Lipid-Based Drug Delivery Nanoplatforms for Colorectal Cancer Therapy

  2020cites this paper
• Nanoparticle-Based Drug Delivery System: A Patient-Friendly Chemotherapy for Oncology

  2020cites this paper
• Targeted Ultrasound Contrast Imaging of Tumor Vasculature With Positively Charged Microbubbles

  2020cites this paper
• Bioelectricity for Drug Delivery: The Promise of Cationic Therapeutics

  2020cites this paper
• PEGylation of paclitaxel-loaded cationic liposomes drives steric stabilization of bicelles and vesicles thereby enhancing delivery and cytotoxicity to human cancer cells.

  2019cites this paper
• Surface Modification of Nanoparticles to Oppose Uptake by the Mononuclear Phagocyte System

  2019cites this paper
• Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release.

  2019cites this paper
• Indocyanine green binds to DOTAP liposomes for enhanced optical properties and tumor photoablation.

  2019cites this paper
• In vivo biocompatibility, pharmacokinetics, antitumor efficacy, and hypersensitivity evaluation of ionic liquid-mediated paclitaxel formulations.

  2019cites this paper
• R

  2019cites this paper
• Multifunctional quantum dots and liposome complexes in drug delivery

  2018cites this paper
• Particles and Nanoparticles in Pharmaceutical Products

  2018influential citation
• Moving Liposome Technology from the Bench to the Oncological Patient: Towards Performance-by-Design

  2018cites this paper
• Nanocarriers in Drug and Gene Delivery

  2018cites this paper
• Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes

  2018influential citation
• Επιφανειακά τροποποιημένοι νανοράβδοι χρυσού για την στοχευμένη χορήγηση αντικαρκινικών ουσιών

  2018cites this paper
• Current taxane formulations and emerging cabazitaxel delivery systems

  2018cites this paper
• Lipid based nanocarriers: a translational perspective.

  2018cites this paper
• Liposomes: Concept and Therapeutic Applications

  2017cites this paper
• Therapeutic prospects of microRNAs in cancer treatment through nanotechnology

  2017cites this paper
• Nanocarriers in cancer clinical practice: a pharmacokinetic issue.

  2017cites this paper
• The battle of “nano” paclitaxel

  2017cites this paper
• Liposome-Encapsulated NaLnF4 Nanoparticles for Mass Cytometry: Evaluating Nonspecific Binding to Cells

  2017cites this paper
• Improved antitumor efficacy of paclitaxel with nano-formulation in breast cancer

  2017cites this paper
• Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come

  2016cites this paper
• Pitfalls and novel applications of particle sizing by dynamic light scattering.

  2016cites this paper
• Injectable Formulations of Poorly Water-Soluble Drugs

  2016cites this paper
• Challenges of Applying Targeted Nanostructures with Multifunctional Properties in Cancer Treatments

  2016cites this paper
• Engineering theranostic liposomes for image guided drug delivery as a novel nanomedicine for cancer therapy

  2016cites this paper
• Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation

  2016cites this paper
• Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma

  2016cites this paper
• Systemic activation of antigen-presenting cells via RNA-loaded nanoparticles

  2016cites this paper
• Targeted delivery of anti-cancer drugs by MS2 virus-like particles

  2015cites this paper
• Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases

  2015cites this paper
• Self-amplifying mRNA vaccines.

  2015cites this paper
• Nanotechnology and Pediatric Cancer: Prevention, Diagnosis and Treatment

  2015cites this paper
• Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics

  2015cites this paper
• New Developments in Liposomal Drug Delivery.

  2015cites this paper
• Role of tumor hypoxia in acquisition of resistance to microtubule-stabilizing drugs.

  2015cites this paper
• Liposomes as a Drug Delivery System

  2015cites this paper
• Bioengineering targeted nanodrugs for hematologic malignancies: An innovation in pediatric oncology

  2015influential citation
• FOLFIRI and sunitinib as first-line treatment in metastatic colorectal cancer patients with liver metastases--a CESAR phase II study including pharmacokinetic, biomarker, and imaging data.

  2014cites this paper
• A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC).

  2014cites this paper
• Phase I/II clinical study on safety and antivascular effects of paclitaxel encapsulated in cationic liposomes for targeted therapy in advanced head and neck cancer

  2014influential citation
• Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery

  2014cites this paper
• Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

  2014cites this paper
• Medical nanoparticles for next generation drug delivery to the lungs

  2014cites this paper
• Targeted Delivery System of Nanobiomaterials in Anticancer Therapy: From Cells to Clinics

  2014cites this paper
• Hemorrhage in mouse tumors induced by dodecaborate cluster lipids intended for boron neutron capture therapy

  2014cites this paper
• Regulatory Aspects of Oncologicals: Nanosystems Main Challenges

  2014cites this paper
• Clinical Nanomedicine: A Solution to the Chemotherapy Conundrum in Pediatric Leukemia Therapy

  2014cites this paper
• Development of liposomal formulations: From concept to clinical investigations

  2013cites this paper
• Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation

  2013cites this paper
• [Recent update of molecular targeted therapy in pancreatic cancer].

  2013cites this paper
• Bioequivalence of Liposome-Entrapped Paclitaxel Easy-To-Use (LEP-ETU) formulation and paclitaxel in polyethoxylated castor oil: a randomized, two-period crossover study in patients with advanced cancer.

  2013cites this paper
• Phase I clinical study of vascular targeting fluorescent cationic liposomes in head and neck cancer

  2013cites this paper
• Liposomal drug delivery systems: from concept to clinical applications.

  2013cites this paper
• Second generation liposomal cancer therapeutics: transition from laboratory to clinic.

  2013cites this paper
• Current trends in the use of liposomes for tumor targeting.

  2013cites this paper
• Bibliography. Head and neck. Current world literature.

  2013cites this paper
• Recent Update of Molecular Targeted Therapy in Pancreatic Cancer

  2013cites this paper
• Molecular targeting of liposomal nanoparticles to tumor microenvironment

  2012influential citation